420 Investor Weekly Review 09/23/22

Review

Canada is finally reviewing the adult-use program. The country saw sales increase sequentially by 4.5% to C$394.8 million in July, up 17.8% from a year ago.

I distributed this written material to 420 Investor subscribers during the week:

Here are some of this week's highlights for Focus List names:

  • ACB reported flat sales at C$50.2 million, predominantly from the medical cannabis market. Its adjusted EBITDA was worse than expected at -C$12.9 million. There was also a large hit to income due to write-downs.
  • AYRWF introduced its brand Lost in Translation into four additional states.
  • CRLBF launched its Cresco brand in Florida.
  • CURLF opened its 18th Pennsylvania medical cannabis dispensary in Allentown. It also closed the acquisition of the majority of Germany's Four 20 Pharma.
  • GNLN launched a new enhanced wholesale shopping experience.
  • GRWG will open a new store in Richmond, Virginia and has two planned for New Jersey and Missouri.'
  • TCNNF gained a Georgia medical cannabis Class 1 license and opened a relocated dispensary in Florida.
  • TLRY received approval to extend in Italy.
  • TRSSF named a new Northeast Region President, Karim Bouaziz, formerly with Parallel and with VidaCann.

There were comments in over 90 discussions in the Forum. Don't miss out on this most informative part of 420 Investor! Not familiar with the the Forum? This video will help! This is a great way to track your favorite tickers, even those not on the Focus List, and to get your questions answered quickly.

Please check the Focus List, (which has technical, fundamental and valuation ratings as well as a market-cap table). To help track market ...

Read More
Comments

420 Investor Weekly Review 09/16/22

Review

Michigan cannabis sales fell 1% sequentially in August due to continued weakness in medical. Sales of $207.9 million, up 26% from a year ago, were supported by a record level of adult-use sales.

I distributed this written material to ...

Read More
Comments

420 Investor Weekly Review 09/09/22

Review

BDSA data for July showed continued modest growth in most of the states that they track sequentially in July. Mature markets in the West fell dramatically from a year ago. Hifyre data suggests that Canadian retail cannabis sales fell ...

Read More
Comments

420 Investor Weekly Review 09/02/22

Review

Illinois adult-use cannabis sales fell 5% sequentially in August, rising 6% from a year ago, to $129.4 million.

I distributed this written material to 420 Investor subscribers during the week:

Read More
Comments

420 Investor Weekly Review 08/26/22

Review

ETFMG is now including MSOs in its MJ ETF. AdvisorShares introduced leverage to its platform for the MSOS ETF. Ohio released data that suggests the state's medical cannabis program is still seeing weekly sales in excess of $9 million. ...

Read More
Comments

420 Investor Weekly Review 08/19/22

Review

Canadian cannabis sales set a record in June! The StatsCan data showed a 1% sequential increase to C$377.5 million, up 22% from the prior year.

I distributed this written material to 420 Investor subscribers during the week:

Read More
Comments

420 Investor Weekly Review 08/12/22

Review

Illinois medical cannabis sales for July were released and left overall sales for the state up 6% from a year ago and just 1.6% sequentially from June. Michigan adult-use flower sales boomed, leaving July sales at a record $210 ...

Read More
Comments

420 Investor Weekly Review 08/05/22

Review

Illinois adult-use cannabis sales lifted 7% sequentially to $135.7 million, up 6.% from a year earlier. Hifyre July data predicts that the month will be a record for sales in Canada, up 7% sequentially from June.

I distributed this ...

Read More
Comments

420 Investor Weekly Review 07/29/22

Review

The House passed a medical cannabis research bill that may be also approved by the Senate.

I distributed this written material to 420 Investor subscribers during the week:

Read More
Comments

420 Investor Weekly Review 07/22/22

Review

StatsCan released data that indicated Canadian sales of cannabis in May set a record of C$375.8 million, up a little sequentially and about 20% from a year ago.

I distributed this written material to 420 Investor subscribers during the ...

Read More
Comments

Weekly Review 07/15/22

Review

After a big down-day on Monday, the market popped on news Thursday that the Senate will be voting on the Cannabis Administration and Opportunity Act. Michigan grew 26% from a year ago and 0.5% from May in June to ...

Read More
Comments

Capitalize On Cannabis Report - 04/15/22

Navigate the fast-moving cannabis sector with 420 Investor, a premium service that sends real-time alerts and explanations of the news below and much more.

Summary

  • New Jersey approved more conditional adult-use licenses and also awarded conditional licenses to the ...
Read More
Comments